Autori: Feagan Brian G
| Naslov | Long-Term Benefit of Golimumab for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the PURSUIT-Maintenance Extension (Article) |
| Autori | Reinisch Walter Gibson Peter R Sandborn William J Feagan Brian G Strauss Richard S Johanns Jewel Padgett Lakshmi Adedokun Omoniyi J Colombel Jean-Frederic Collins Judith Rutgeerts Paul Tarabar Dino K Marano Colleen W |
| Info | JOURNAL OF CROHNS & COLITIS, (2018), vol. 12 br. 9, str. 1053-1066 |
| Projekat | Janssen Research & Development, LLC, Spring House, PA, USA |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Maintenance of Efficacy and Continuing Safety of Golimumab for Active Ulcerative Colitis: PURSUIT-SC Maintenance Study Extension Through 1 Year (Article) |
| Autori | Gibson Peter R Feagan Brian G Sandborn William J Marano Colleen W Strauss Richard S Johanns Jewel Padgett Lakshmi Collins Judith Tarabar Dino K Hebzda Zbigniew Rutgeerts Paul Reinisch Walter |
| Info | CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, (2016), vol. 7 br. , str. - |
| Projekat | Janssen Research & Development, LLC (Spring House, PA, USA) |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Delayed-Release Oral Mesalamine 4.8 g/day (800-mg Tablet) Is Effective for Patients With Moderately Active Ulcerative Colitis (Article) |
| Autori | Sandborn William J Regula Jaroslaw Feagan Brian G Belousova Elena Jojic Njegica Z Lukas Milan Yacyshyn Bruce Krzeski Piotr Yeh Chyon-Hwa Messer Christi A Hanauer Stephen B |
| Info | GASTROENTEROLOGY, (2009), vol. 137 br. 6, str. 1934-1943 |
| Projekat | Procter & Gamble Pharmaceuticals, Inc, Mason, Ohio |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
